Smallpox is a highly contagious disease caused by the variola virus, with a high mortality rate. Treatment primarily focuses on prevention and antiviral medications. The main strategies include vaccination and novel antiviral drugs to block virus transmission, inhibit viral replication, and reduce mortality. Since the World Health Organization declared the eradication of natural smallpox infection in 1980, treatment efforts have shifted towards preparedness against potential bioterrorism or laboratory accidents.
1. Smallpox Vaccine: Live attenuated vaccines (such as ACAM2000) stimulate the body to produce neutralizing antibodies, providing active immunity. After vaccination, a localized infection develops in the skin, inducing T-cell and B-cell memory responses. 2. Antiviral Drugs: For example, tecovirimat (TPOXX) inhibits the viral p35 protein, preventing the virus from detaching from the host cell membrane and thereby blocking the release of infectious virions.
The vaccine is mainly used for high-risk groups such as laboratory personnel or healthcare workers exposed to the virus. Antiviral drugs are suitable for confirmed or suspected smallpox cases, especially when early symptoms (such as fever and rash) appear.
The vaccine is administered via scarification or subcutaneous injection. Local pustular reactions are monitored to confirm immune response. The adult dose is 0.5 ml injected intradermally, which can produce sufficient immunity after 4 weeks. Tecovirimat is recommended at 600 mg orally every 12 hours; in severe cases, intravenous administration may be used, with a treatment course lasting 14 days.
Vaccination may cause local redness, swelling, fever, and other mild reactions. Immunocompromised individuals have a 0.01% risk of developing disseminated vaccinia infection. Common side effects of antiviral drugs include headache and nausea; rarely, transient elevation of liver enzymes may occur.
Contraindications:
Pre-vaccination assessment of health status is necessary, and contact with immunocompromised persons should be avoided within 4 weeks post-vaccination.
Concurrent use with immunosuppressants (such as corticosteroids) can reduce vaccine efficacy; a minimum interval of 4 weeks is recommended. Combining antiviral drugs with CYP3A4 enzyme inducers (like rifampin) may require dosage adjustments.
Historical data show a 98% reduction in disease incidence among vaccinated contacts. Clinical trials in 2018 confirmed that tecovirimat reduced infection-related mortality by 75%. In monkey models, the drug decreased lung viral load by 99%.
Second-line options include broad-spectrum antivirals such as brincidofovir, which may carry a risk of nephrotoxicity. Supportive treatments like fluids and antipyretics can alleviate symptoms but do not directly eliminate the virus.
Minor reactions such as fever, headache, or fatigue may occur after vaccination and usually resolve within 24 to 48 hours. Rest, hydration, and antipyretics (e.g., acetaminophen) can help relieve symptoms. If fever exceeds 39°C or persists beyond 48 hours, seek medical attention promptly for further assessment.
What precautions should I take regarding diet or daily activities during antiviral treatment?It is recommended to consume high-protein, nutritious foods to promote skin healing, and avoid spicy or irritating foods. Strict disinfection of environments exposed to patient secretions is necessary to prevent transmission. Patients should avoid public places during treatment. Follow medical advice for regular follow-up and do not discontinue medication without consultation.
What long-term health management is needed for recurrent smallpox cases after treatment?Patients should undergo ongoing immune function monitoring, and doctors may recommend regular antibody level testing. Maintain good hygiene and avoid environments that may expose to infectious agents. If symptoms recur, seek medical attention promptly to adjust treatment.
What health conditions should be disclosed before smallpox vaccination?Individuals with immunodeficiency, pregnancy, allergies to vaccine components, or a history of severe vaccine reactions should inform their healthcare provider beforehand. Those undergoing radiation therapy or corticosteroid treatment should also be evaluated for risks. The healthcare provider will determine vaccination suitability based on individual health status.
How can I prevent scars or infections during skin healing after treatment?Keep the wound clean and dry during healing, avoid scratching blisters or scabs. Use prescribed antibacterial ointments to prevent infection and follow instructions for antipruritic medications. After healing, consult healthcare professionals for scar reduction treatments. Do not attempt to treat damaged skin with homemade remedies.
%201.svg)
Copyright © 2025 MedFrontiers. All Rights Reserved.
